ad image

Community

Adam Lauber
Adam Lauber

Chief Financial Officer, Andelyn Biosciences

Adam Lauber joined as Andelyn’s Chief Financial Officer in 2020, bringing a successful track record of managing aggressive growth and successful liquidity events in the outsourced pharma services sector. He started his career with Deloitte’s Assurance practice, before joining as the Controller of a WI-based API manufacturer. Over the next decade, he would oversee the company’s massive growth to become the diversified integrated global CDMO, Alcami Corporation. Adam received his undergraduate degree in Accounting, Finance, Investment, and Banking from the University of Wisconsin, Madison, where he also received his Master’s of Accountancy.